Serdar Inci
Lawyers
Filters
Forbion European Acquisition $126.5 million IPO
We advised Forbion European Acquisition, a SPAC, on its IPO and Nasdaq listing
Target Global Acquisition I $200 million IPO
We advised Target Global Acquisition I, a SPAC, on its IPO and Nasdaq listing
Mountain & Co. I Acquisition $230 million IPO
We advised the SPAC on its IPO and Nasdaq listing
AngloGold Ashanti $750 million debt offering and cash tender offer
The company issued 3.375% notes due 2028 and offered to purchase its outstanding 5.125% notes due 2022
Levere Holdings $250 million IPO
We advised the underwriters on the SPAC IPO and Nasdaq listing
Anglo American $1 billion notes offering
We advised the underwriters on the Rule 144A senior notes offering
Oncopeptides SEK 1.1 billion private placing of new shares
We advised Oncopeptides on the private placement of shares
Deutsche Bank $1.25 billion subordinated Tier 2 notes offering
We advised the underwriters in connection with the SEC-registered offering
Xspray Pharma SEK 265 million private placing of new shares
Davis Polk advised Xspray Pharma AB (publ) on a private placing of new shares. The private placing raised gross proceeds of approximately SEK 265 million.
Xspray was founded in 2003…
Smith+Nephew $1 billion notes offering
Davis Polk advised Smith & Nephew plc in connection with the establishment of a WKSI shelf and its debut SEC-registered shelf takedown of $1 billion aggregate principal amount of 2.032%…